David V Smith
CIK 1229447 · Executive Vice President & CFO · last filed 2025-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$466.3K
Companies
6
Total Filings
50
Lifetime Open-Market Net
-$1.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CDXS | Director | 194,275 | $2.40 | $466.3K | -$62.2K | 12 | 2025-06-12 |
| IO Biotech, Inc. (IOBT) Delisted | Director | — | $0.05 | — | $0 | 5 | 2025-06-06 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Executive Vice President & CFO | 138,947 | $38.00 | $5.28M | $0 | 7 | 2021-04-19 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Executive Vice President & CFO | 40,000 | $178.75 | $7.15M | $0 | 2 | 2019-06-26 |
| ACHIEVE LIFE SCIENCES, INC. (OGXI) Delisted | Director | 9,500 | — | — | $0 | 6 | 2016-05-27 |
| THORATEC CORP (THOR) Delisted | CFO & EVP | 64,591 | — | — | -$1.33M | 18 | 2011-03-17 |
Recent Filings · Page 2 of 5
50 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-19 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Mixed | −72,947 | -$5.28M | EDGAR |
| 2021-02-26 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Tax (F) | −5,110 | -$131.4K | EDGAR |
| 2020-12-15 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Mixed | +10,496 | -$185.7K | EDGAR |
| 2020-11-30 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Tax (F) | −6,920 | -$127.7K | EDGAR |
| 2020-11-13 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Mixed | +11,092 | -$196.3K | EDGAR |
| 2020-06-18 | CDXS | Mixed | +4,005 | $0 | EDGAR |
| 2020-03-11 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Grant (A) | +30,000 | $0 | EDGAR |
| 2019-11-27 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Tax (F) | −6,611 | -$24.9K | EDGAR |
| 2019-06-26 | FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-13 | CDXS | Grant (A) | +4,947 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.